Jay G. Wohlgemuth, MD

Jay G. Wohlgemuth, MD, is senior vice president, research and development, medical/chief medical officer, for Quest Diagnostics. Based at Quest Diagnostics Nichols Institute, in San Juan Capistrano, Calif., Dr. Wohlgemuth is responsible for research and development, medical affairs and medical/lab quality. In addition, he is responsible for improving outcomes for employees who use our health benefits.

Dr. Wohlgemuth has many years of experience in medical diagnostics and research and development. He rejoined Quest in 2016 from HealthTap, a health information start-up, where he served as senior vice president/chief healthcare officer. Prior to that, he was senior vice president, research and development, medical/chief scientific officer with Quest. Dr. Wohlgemuth originally joined Quest in 2009 from Genentech, where he was director, clinical diagnostics, ITGR (Immunology, Tissue Growth and Repair) and global development team leader for ocrulizumab. He also served as vice president, research and development for VIA Pharmaceuticals, and as chief medical officer for the molecular diagnostics company XDx, a company he co-founded. Dr. Wohlgemuth also served as vice president, research and development for XDx. For his work at XDx he was awarded Technology Pioneer 2005 at the World Economic Forum in Davos, Switzerland. He serves on the board of directors for the Personalized Medicine Coalition, Diagnostic Labs of Oklahoma and The Anne and Henry Zarrow Charitable Foundation.

Dr. Wohlgemuth earned his bachelor’s degree in biology from Harvard College and his medical degree from Stanford University School of Medicine, where he also completed a fellowship in cardiovascular medicine.